4//SEC Filing
Donato Peter 4
Accession 0001209191-19-018606
CIK 0001227636other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 7:11 PM ET
Size
19.2 KB
Accession
0001209191-19-018606
Insider Transaction Report
Form 4
Donato Peter
Vice President and CFO
Transactions
- Exercise/Conversion
Common Stock
2019-03-08$3.19/sh+8,177$26,085→ 8,177 total - Award
Common Stock
2019-03-08+14,007→ 14,007 total - Exercise/Conversion
Common Stock
2019-03-07$3.19/sh+18,061$57,615→ 18,061 total - Award
Employee Stock Option (right to buy)
2019-03-08+24,652→ 24,652 totalExercise: $16.42Exp: 2029-03-08→ Common Stock (24,652 underlying) - Sale
Common Stock
2019-03-07$16.21/sh−18,061$292,769→ 0 total - Sale
Common Stock
2019-03-08$16.01/sh−8,177$130,914→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-03-07−18,061→ 86,890 totalExercise: $3.19Exp: 2027-04-11→ Common Stock (18,061 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-03-08−8,177→ 78,713 totalExercise: $3.19Exp: 2027-04-11→ Common Stock (8,177 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.525 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.085 inclusive.
- [F3]Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
- [F6]Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Neuronetics, Inc.
CIK 0001227636
Entity typeother
Related Parties
1- filerCIK 0001408320
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 7:11 PM ET
- Size
- 19.2 KB